Telesis Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 27th of September, 2024.
1 hedge funds and large institutions have $178K invested in Telesis Bio, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 10 closing their positions.
31.08% less ownership
Funds ownership: 33.7% → 2.62% (-31%)
90% less funds holding
Funds holding: 10 → 1 (-9)
90% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 10
91% less capital invested
Capital invested by funds: $2.05M → $178K (-$1.88M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NV
Northpond Ventures
Bethesda,
Maryland
|
-$2M |
| 2 |
Millennium Management
New York
|
-$47.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.96K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.23K |
| 5 |
DWS
Dynamic Wealth Strategies
Granite Bay,
California
|
-$1K |
TBIO Hedge Fund Activity: Q3 2024 in Review
1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q3 2024, worth a combined $178K — down 91% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TBIO and 1 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Clear Street, opening a new position worth an estimated $164K. The largest seller was Northpond Ventures, exiting entirely with an estimated $2M sold.
- 1 institutional investor held Telesis Bio, Inc. Common Stock (TBIO) as of Q3 2024, down from 10 in Q2 2024.
- Funds reported $178K of Telesis Bio, Inc. Common Stock stock for Q3 2024, down 91% quarter-over-quarter.
- 1 fund opened new Telesis Bio, Inc. Common Stock positions in Q3 2024 and 10 closed out, a net change of -9 holders.
- The largest Telesis Bio, Inc. Common Stock buyer in Q3 2024 was Clear Street, an estimated $164K added.
- The largest Telesis Bio, Inc. Common Stock seller in Q3 2024 was Northpond Ventures, an estimated $2M sold.
Based on aggregated 13F filings for Q3 2024.